# SCENESSE
> **NDA210797** · New Drug Application · Sponsor: CLIVUNEL INC · Approved 2019-10-08
## Drug
- **FDA Application Number:** NDA210797
- **Application type:** New Drug Application
- **Brand name:** SCENESSE
- **Generic name:** AFAMELANOTIDE
- **Active ingredients:** AFAMELANOTIDE
- **Dosage form:** IMPLANT
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** CLIVUNEL INC
- **Manufacturer:** CLINUVEL INC.
- **First approval:** 2019-10-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210797)
---
*MORVS · CC0 1.0*